Replies to post #215634 on Biotech Values

[DewDiligence]

RARX sells 9.66M* shares @$6.00—an 8% discount to yesterday’s close:

https://finance.yahoo.com/news/ra-pharmaceuticals-announces-pricing-public-141300214.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

UCB.BR acquires RARX for $48/sh cash—112% premium to yesterday’s lose:

https://finance.yahoo.com/news/ucb-agrees-acquire-ra-pharmaceuticals-110000368.html

The nominal deal value is $2.1B.

CC at 9am ET.